Carl Borrebaeck is a professor at the Department of Immunotechnology and program director of the CREATE translational cancer research center at Lund University. He is an entrepreÂneur and founded SenzaGen AB and several other life science companies, including Immunovia AB and BioInÂvent International AB. He is also a founding mentor for the Nordic MenÂtor Network for Entrepreneurship (NOME), a member of the Royal SwedÂish Academy of Engineering Sciences (IVA) and a former vice-chancellor at Lund University. Carl has won a numÂber of awards for his entrepreneurÂship and groundbreaking research, including AkzoNobel’s Science Prize in 2009 and the Biotech Builder Award in 2017.